During this global crisis, the safety of our employees and the public, including health care workers and first responders fighting COVID-19, is our highest priority.



We are making more respirators than ever before. Since January, we have doubled global N95 respirator production and are on track to increase our capacity to produce N95 and other respirators to 2 billion per year globally by the end of 2020.



As we further increase production of N95 respirators in the U.S. and import additional respirators from our plants in Asia, we can continue supporting the critical needs of health care workers, while also supporting workplace safety – enabling a limited re-opening of the economy.



Demand for personal protective equipment continues to far exceed supply for the entire industry. We continue to work with governments, health agencies, distributors and others to prioritize supplies to the most critical customer and public health needs.



3M is also partnering with others on innovative solutions, including investigating ways for hospitals to decontaminate, reuse and extend the life of N95 respirators under FDA Emergency Use Authorizations, helping Ford Motor Company rapidly design a new powered air-purifying respirator (PAPR), partnering with engine manufacturer Cummins to increase production of high-efficiency particulate filters for use in 3M PAPRs, and collaborating with MIT to develop a rapid diagnostic test for COVID-19.



We are grateful for the work our people are doing to support the public health response and are taking actions to protect and support them, including offering remote work when possible and providing robust safety protocols in our facilities.